PharmAla Provides Comprehensive Investor Update Following Release of Q3 Financial Statement
PremiumPress ReleasesPharmAla Provides Comprehensive Investor Update Following Release of Q3 Financial Statement
1M ago
PharmAla Biotech Rolls Out Educational MDMA Portal
Premium
Company Announcements
PharmAla Biotech Rolls Out Educational MDMA Portal
4M ago
PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy
Premium
Press Releases
PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy
4M ago
PharmAla Advances Australian Psychedelic Therapy
PremiumCompany AnnouncementsPharmAla Advances Australian Psychedelic Therapy
5M ago
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
Premium
Press Releases
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
5M ago
PharmAla Biotech’s MDMA Patent Paves New Therapeutic Paths
Premium
Company Announcements
PharmAla Biotech’s MDMA Patent Paves New Therapeutic Paths
5M ago
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
PremiumPress ReleasesPatent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
5M ago
PharmAla Pioneers Psilocybin Supply in Australia
Premium
Company Announcements
PharmAla Pioneers Psilocybin Supply in Australia
6M ago
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
Premium
Press Releases
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100